Prime MedTech: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Prime MedTech
Largest movements
- Receivables within one year +€48,690
up €48,690 (+168.1%), from €28,957 to €77,647
of which Trade receivables: +€55,668
- Cash -€38,980
down €38,980 (-30.2%), from €129,033 to €90,053
mainly Contributions, distributions and other (-€269,375) and Receivables within one year (-€48,690)
- Current investments +€18,681
up €18,681 (+20.8%), from €89,818 to €108,498
- Tangible fixed assets -€15,083
down €15,083 (-89.4%), from €16,875 to €1,792
of which Furniture and vehicles: -€14,245
- Other debts +€190,338
up €190,338 (+370.5%), from €51,367 to €241,705
- Reserves -€97,000
down €97,000 (-100.0%), from €97,000 to €0
- Profit (loss) carried forward -€78,021
down €78,021 (-89.3%), from €87,375 to €9,354
- Gross operating margin +€32,481
up €32,481 (+29.2%), from €111,218 to €143,699
- Taxes +€13,544
up €13,544 (+67.0%), from €20,202 to €33,746
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €265,309 | €278,942 | +€13,633 | +5.1% |
| Fixed assets | 21/28 | €16,875 | €1,792 | -€15,083 | -89.4% |
| Tangible fixed assets | 22/27 | €16,875 | €1,792 | -€15,083 | -89.4% |
| Plant, machinery and equipment | 23 | €1,681 | €843 | -€838 | -49.9% |
| Furniture and vehicles | 24 | €15,193 | €949 | -€14,245 | -93.8% |
| Current assets | 29/58 | €248,434 | €277,150 | +€28,716 | +11.6% |
| Amounts receivable within one year | 40/41 | €28,957 | €77,647 | +€48,690 | +168.1% |
| Trade receivables | 40 | €19,645 | €75,312 | +€55,668 | +283.4% |
| Other amounts receivable | 41 | €9,313 | €2,335 | -€6,978 | -74.9% |
| Current investments | 50/53 | €89,818 | €108,498 | +€18,681 | +20.8% |
| Cash at bank and in hand | 54/58 | €129,033 | €90,053 | -€38,980 | -30.2% |
| Deferred charges and accrued income | 490/1 | €627 | €952 | +€325 | +51.8% |
| Total equity and liabilities | 10/49 | €265,309 | €278,942 | +€13,633 | +5.1% |
| Equity | 10/15 | €202,975 | €27,954 | -€175,021 | -86.2% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €97,000 | €0 | -€97,000 | -100.0% |
| Distributable reserves | 133 | €97,000 | €0 | -€97,000 | -100.0% |
| Profit (loss) carried forward | 14 | €87,375 | €9,354 | -€78,021 | -89.3% |
| Amounts payable | 17/49 | €62,334 | €250,988 | +€188,654 | +302.6% |
| Amounts payable within one year | 42/48 | €62,334 | €250,988 | +€188,654 | +302.6% |
| Trade debts | 44 | €1,331 | €2,329 | +€998 | +75.0% |
| Suppliers | 440/4 | €1,331 | €2,329 | +€998 | +75.0% |
| Taxes, remuneration and social security | 45 | €9,636 | €6,954 | -€2,682 | -27.8% |
| Taxes | 450/3 | €9,636 | €6,954 | -€2,682 | -27.8% |
| Other amounts payable | 47/48 | €51,367 | €241,705 | +€190,338 | +370.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €14,399 | €15,083 | +€684 | +4.7% |
| Other operating charges | 640/8 | €529 | €1,283 | +€755 | +142.8% |
| Gross operating margin | 9900 | €111,218 | €143,699 | +€32,481 | +29.2% |
| Operating profit (loss) | 9901 | €96,291 | €127,333 | +€31,042 | +32.2% |
| Financial income | 75/76B | €283 | €973 | +€690 | +243.3% |
| Recurring financial income | 75 | €283 | €973 | +€690 | +243.3% |
| Financial charges | 65/66B | €912 | €206 | -€705 | -77.4% |
| Recurring financial charges | 65 | €912 | €206 | -€705 | -77.4% |
| Profit (loss) for the period before taxes | 9903 | €95,662 | €128,100 | +€32,437 | +33.9% |
| Income taxes | 67/77 | €20,202 | €33,746 | +€13,544 | +67.0% |
| Profit (loss) for the period | 9904 | €75,461 | €94,354 | +€18,893 | +25.0% |
| Profit (loss) for the period to be appropriated | 9905 | €75,461 | €94,354 | +€18,893 | +25.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.